Special attention should be paid to antibiotic resistance, medication adherence, and monitoring of adverse reactions when using VonosapPack for eradicating Helicobacter pylori.

1. Core storage conditions

(1) Temperature: It should be stored in a room temperature environment of 20 ° C to 25 ° C (68 ° F to 77 ° F), with a short-term fluctuation range of 15 ° C to 30 ° C (59 ° F to 86 ° F) allowed.

(2) Humidity: All components must be kept sealed in their original packaging and placed in a dry environment to avoid moisture.

2. Special component requirements

(1) Proton pump inhibitors: Aluminum plastic blister packaging should avoid puncture damage.

(2) Antibiotic tablets: Clarithromycin should be stored in the dark with special attention.

3. Prohibited storage methods

(1) All components must not be refrigerated or frozen, as low temperatures can cause changes in the drug crystal form.

(2) Do not transfer drugs to non original containers for storage.

4. Safety storage measures

(1) It should be placed at a height that children cannot reach or in a locked cabinet.

(2) Avoid mixing with food and beverages to prevent accidental ingestion.

5. Exception handling

(1) If the packaging is damaged or the medicine changes color, it should be stopped immediately.

(2) Expired drugs need to be recycled and disposed of through professional institutions.

6. Standardized medication time

(1) Proton pump inhibitors should be taken on an empty stomach 30 minutes before breakfast.

(2) Antibiotics should be administered evenly every 12 hours, and clarithromycin should be avoided from being taken with dairy products.

7. Adverse reaction management

(1) Stop taking medication immediately and seek medical attention when severe diarrhea accompanied by dehydration occurs.

(2) Metallic taste can be alleviated by taking vitamin C lozenges.

8. Taboos

(1) Amoxicillin containing regimens are contraindicated for individuals allergic to penicillin.

(2) Drinking alcohol is prohibited during and 72 hours after treatment.

9. Medication for special populations

(1) Pregnant women are prohibited from using regimens containing clarithromycin and metronidazole.

(2) Patients with abnormal liver function need to adjust the dosage of bismuth agents.

10. Treatment monitoring requirements

(1) Evaluate the improvement of symptoms after 7 days of medication.

(2) After 4 weeks of treatment, a follow-up urea breath test is required.